NASDAQ: ALIM       Alimera Sciences Inc
Last Price Today's Change   Day's Range   Trading Volume
5.10   -0.16 (3.04%)  5.10 - 5.42  3,446


Avg Volume (4 weeks):10,021
4 Weeks Range:4.77 - 6.01
4 Weeks Price Volatility (%):
52 Weeks Range:0.197 - 9.98
52 Weeks Price Volatility (%):
Average Price Target: 2.00
Price Target Upside/Downside: -3.10


No recent Headlines for this stock.

Business Background

Alimera Sciences Inc is a pharmaceutical company. It specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. The product portfolio of the company includes ILUVIEN, which is developed to treat diabetic macular edema. In addition, to the activities related to the development of ILUVIEN, the group is also researching the safety and effectiveness of NADPH (Nicotinamide Adenine Dinucleotide Phosphate) oxidase inhibitors. Geographically it operates through the region of US and also it has its presence in the international market.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1963  3736  340  2912 

Top 10 Active Counters
 JCP 0.1820.00 
 AVP 5.60-0.05 
 GE 6.505-0.275 
 ADAP 11.342+6.482 
 PHIO 4.17+1.93 
 PRTY 1.345+0.325 
 AABA 19.630.00 
 TGE 22.39+0.81 
 NCLH 15.276-0.794 
 SQQQ 9.825-0.005 
Partners & Brokers